Office for Clinical Trials

The Office for Clinical Trials supports the conduct of investigational new drug (IND) registration trials, including sponsored and investigator-initiated trials. More than 160 IND trials, including 30-40 trials newly contracted every year, are being conducted constantly at our facility. Our hospital is one of the top clinical trial-conducting hospitals in Japan. The rate of patients that are actually treated compared to the total number of presenting patients is around 90%, which is extremely high.

Our office staff consist of 17 qualified Clinical Research Coordinators (CRCs; 3 pharmacists and 14 nurses) and 7 support staff. More than 60% of the trials are global studies, and we have created an advanced system capable of responding to audits or inspections from regulatory authorities both in Japan and overseas.

The accuracy and speed of CRCs’ efforts are highly esteemed and trusted by the sponsors, and many of our CRCs have received awards for their work.

Office for Clinical Research

The Office for Clinical Research supports the conduct of specified clinical trials according to the Clinical Trials Act and investigator-initiated interventional and observational studies according to the Ethical Guidelines for Medical and Health Research Involving Human Subjects.

Our office staff consist of eight members (four CRCs and four clerks). They support the management of clinical studies and the office work of the Ethics Review Board of our hospital. At present, over 500 clinical studies are ongoing.

Greater quality control is being required in order to conduct clinical research. All clinical research work should be done in close coordination with other departments in the hospital. We are working hard to deliver new medicines to cancer patients as soon as possible.

Head: Taito Esaki, M.D.